Triple
T7392986
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | George Church |
E170546
|
entity |
| Predicate | coFounded |
P104
|
FINISHED |
| Object |
eGenesis
eGenesis is a biotechnology company focused on using advanced gene-editing technologies to make animal organs safe and suitable for human transplantation.
|
E661990
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: eGenesis | Statement: [George Church, coFounded, eGenesis]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: eGenesis Context triple: [George Church, coFounded, eGenesis]
-
A.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
B.
Yamanaka factors
Yamanaka factors are a set of transcription factors that can reprogram adult somatic cells into induced pluripotent stem cells, revolutionizing regenerative medicine and stem cell research.
-
C.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
D.
H3 Biomedicine
H3 Biomedicine is a biotechnology company focused on discovering and developing precision cancer therapies using genomics-driven approaches.
-
E.
Regenesis Group
Regenesis Group is a sustainability-focused organization known for advancing green building and regenerative development practices.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: eGenesis Triple: [George Church, coFounded, eGenesis]
Generated description
eGenesis is a biotechnology company focused on using advanced gene-editing technologies to make animal organs safe and suitable for human transplantation.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: eGenesis Target entity description: eGenesis is a biotechnology company focused on using advanced gene-editing technologies to make animal organs safe and suitable for human transplantation.
-
A.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
B.
Yamanaka factors
Yamanaka factors are a set of transcription factors that can reprogram adult somatic cells into induced pluripotent stem cells, revolutionizing regenerative medicine and stem cell research.
-
C.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
D.
H3 Biomedicine
H3 Biomedicine is a biotechnology company focused on discovering and developing precision cancer therapies using genomics-driven approaches.
-
E.
Regenesis Group
Regenesis Group is a sustainability-focused organization known for advancing green building and regenerative development practices.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c68a5e2c9081909e713ce866e0060a |
completed | March 27, 2026, 1:47 p.m. |
| NER | Named-entity recognition | batch_69c6f224790c819099ceb7c7ac8d00f6 |
completed | March 27, 2026, 9:09 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c810f82ba08190919924b0994a2eee |
completed | March 28, 2026, 5:33 p.m. |
| NEDg | Description generation | batch_69c811f1fe3c8190a591186b19044b5f |
completed | March 28, 2026, 5:37 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69c812c1e9d08190b0e7f052d87011b9 |
completed | March 28, 2026, 5:41 p.m. |
Created at: March 27, 2026, 3:09 p.m.